0001209191-23-041689.txt : 20230706
0001209191-23-041689.hdr.sgml : 20230706
20230706190248
ACCESSION NUMBER: 0001209191-23-041689
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230703
FILED AS OF DATE: 20230706
DATE AS OF CHANGE: 20230706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tipirneni Praveen P.
CENTRAL INDEX KEY: 0001779978
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38940
FILM NUMBER: 231074852
MAIL ADDRESS:
STREET 1: C/O MORPHIC HOLDING, INC.,
STREET 2: 35 GATEHOUSE DRIVE, A2
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Morphic Holding, Inc.
CENTRAL INDEX KEY: 0001679363
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473878772
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE A2
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 9787296480
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE A2
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Morphic Holding, LLC
DATE OF NAME CHANGE: 20160712
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-07-03
0
0001679363
Morphic Holding, Inc.
MORF
0001779978
Tipirneni Praveen P.
C/O MORPHIC HOLDING, INC.
35 GATEHOUSE DRIVE, A2
WALTHAM
MA
02451
1
1
0
0
President and CEO
0
Common Stock
2023-07-03
4
M
0
3597
4.32
A
17533
D
Common Stock
2023-07-03
4
S
0
3597
57.0413
D
13936
D
Stock Option (right to buy Common Stock)
4.32
2023-07-03
4
M
0
3597
0.00
D
2028-12-14
Common Stock
3597
364740
D
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder dated September 16, 2022.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.61 to $57.52 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
This option is fully vested.
/s/ Robert Farrell as attorney-in-fact for Praveen P. Tipirneni
2023-07-06